LVTX

LAVA Therapeutics N.V. Ordinary Shares (LVTX)

About LAVA Therapeutics N.V. Ordinary Shares (LVTX)

LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.

Details

Daily high

$1.03

Daily low

$0.97

Price at open

$0.98

52 Week High

$6.47

52 Week Low

$0.96

Market cap

27.1M

Dividend yield

0.00%

Volume

157,263

Avg. volume

179,988

P/E ratio

-1.00

LAVA Therapeutics N.V. Ordinary Shares News